...ia nurse researcher is among the first in the nati...us funding through the American Recovery and Reinv...nt will support at least three jobs and the resear...ho may suffer from cocaine-related renal disease. ... 3.5 million jobs over the next two years. , "It,...
...as key to Komodo Dragon,s hunting strategy. , A n...omodo Dragon bite is a combination of highly speci...dismiss the widely accepted theory that prey die f...the dragon,s mouth. , Using sophisticated medical...Dr Bryan Fry from the University of Melbourne have...
...the active site found in a naturally occurring enz...escribed a catalyst that acts like nature,s most p...cribe their work in a paper accepted for publicati...y , and posted on the journal,s Web site. , Scient... use cheap and plentiful building blocks iron, ni...
Other Biology News:MCG researcher among first to receive NIH stimulus funding 2A combined tooth-venom arsenal revealed as key to Komodo dragon's hunting strategy 2(Date:11/30/2009)...RUSSIA, Pa., Nov. 30 Cadient Inte...n interactive marketing services and solutions fo...nch of its HATCH Consulting services group (...ategic experts across a range of emerging areas of...ng team is committed to guiding companies and bran...
(Date:11/30/2009)...ovember 30 Biopharmaceutical compa...tients have been enrolled in its,multinational reg...is,designed to show reduction in transplant relate...geneic stem cell transplantation with a mismatched...eligible for an allogeneic,stem cell transplantati...
(Date:11/30/2009)..., a leader in providing smart and efficient softwa...Pathology®, evolutionizing work-from-home hist...ard’ software used by 8 of the Top 10 Pharma...ost per slide’ basis. , ... -- PDS has announced another evolution in the his...
(Date:11/30/2009)... , AMSTERDAM, November 30 /PRNewswire-Fir... of scientific, medical and technical products and...base, its comprehensive biomedical,database which ...an 7,000,active, peer reviewed journals. , ...ment of new biomedical,and pharmaceutical insights...
Breaking Biology Technology:Cadient Interactive Announces the Launch of HATCH Consulting Services 2Cadient Interactive Announces the Launch of HATCH Consulting Services 3Kiadis Pharma Announces Enrollment of First Patients in a Multinational Registration Study for ATIR(TM) 2Pajama Pathology -- the New Wave of Preclinical Pathology Embraced by PDS 2Pajama Pathology -- the New Wave of Preclinical Pathology Embraced by PDS 3Elsevier is Re-Launching "Embase" to be a Powerful Resource Providing Deep Insights and Answers to Biomedical Researchers 2Elsevier is Re-Launching "Embase" to be a Powerful Resource Providing Deep Insights and Answers to Biomedical Researchers 3...: INSM ), a biopharmaceutical company, today rep..., 2009. , , Recent Company Highlights , , , ... Finalized sale of follow-on biologics (FOB) as...e, for gross proceeds of $130 million; and , ...s received net proceeds to date of approximately $...
...egy and Process for Picoplatin - , , SOUTH SAN FR...Inc. (Nasdaq: PARD ), a biopharmaceutical compan...announced that Ronald Martell, president and chief...ational Convention on Tuesday, May 19, at 3:20 p.m...de an overview of the Company,s lead product candi...
...y leader to acquire 105 MGY of additional capacity.... , Ames, Iowa (Vocus) Ma...nounced it has entered into agreements to consolid...Western Iowa Energy, which operates a 30 MGY facil...which operates a 30 MGY facility Newton, Iowa; and...
Other Biology Technology:Insmed Announces First Quarter 2009 Financial Results 2Insmed Announces First Quarter 2009 Financial Results 3Insmed Announces First Quarter 2009 Financial Results 4Insmed Announces First Quarter 2009 Financial Results 5Insmed Announces First Quarter 2009 Financial Results 6Insmed Announces First Quarter 2009 Financial Results 7Insmed Announces First Quarter 2009 Financial Results 8Insmed Announces First Quarter 2009 Financial Results 9Poniard Pharmaceuticals to Present at the 2009 BIO International Convention 2Poniard Pharmaceuticals to Present at the 2009 BIO International Convention 3REG Signs Agreement with Three Biodiesel Plants to Consolidate 2REG Signs Agreement with Three Biodiesel Plants to Consolidate 3REG Signs Agreement with Three Biodiesel Plants to Consolidate 4REG Signs Agreement with Three Biodiesel Plants to Consolidate 5REG Signs Agreement with Three Biodiesel Plants to Consolidate 6REG Signs Agreement with Three Biodiesel Plants to Consolidate 7GRADIENT MAKER, 30 ML from GE Healthcare, formerly Amersham Biosciences
...rnandez and G. Butcher (1998). • The major hi...search in the immunology area. There is great inte... function as antigen-presenting molecules. Many im...ackling biochemical and genetic techniques in orde...
DALT GRADIENT MAKER,230V from GE Healthcare, formerly Amersham Biosciences
Actin from Molecular Probes (Invitrogen)
Biology Products: